NewGenIvf Group Statistics
Total Valuation
NewGenIvf Group has a market cap or net worth of $5.64 million. The enterprise value is $9.55 million.
Important Dates
The last earnings date was Tuesday, June 9, 2026.
| Earnings Date | Jun 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NewGenIvf Group has 10.07 million shares outstanding.
| Current Share Class | 9.96M |
| Shares Outstanding | 10.07M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +287.33% |
| Owned by Insiders (%) | 1.13% |
| Owned by Institutions (%) | 0.20% |
| Float | 9.96M |
Valuation Ratios
The trailing PE ratio is 0.18 and the forward PE ratio is 0.12.
| PE Ratio | 0.18 |
| Forward PE | 0.12 |
| PS Ratio | 1.19 |
| Forward PS | n/a |
| PB Ratio | 0.01 |
| P/TBV Ratio | 1.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 0.97 |
| EV / Sales | 2.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.12, with a Debt / Equity ratio of 0.19.
| Current Ratio | 3.12 |
| Quick Ratio | 0.83 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -17.40 |
Financial Efficiency
Return on equity (ROE) is 79.40% and return on invested capital (ROIC) is -33.70%.
| Return on Equity (ROE) | 79.40% |
| Return on Assets (ROA) | -36.94% |
| Return on Invested Capital (ROIC) | -33.70% |
| Return on Capital Employed (ROCE) | -35.34% |
| Weighted Average Cost of Capital (WACC) | 6.67% |
| Revenue Per Employee | $54,327 |
| Profits Per Employee | $113,556 |
| Employee Count | 87 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 15.36 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.82% in the last 52 weeks. The beta is -0.08, so NewGenIvf Group's price volatility has been lower than the market average.
| Beta (5Y) | -0.08 |
| 52-Week Price Change | -99.82% |
| 50-Day Moving Average | 1.15 |
| 200-Day Moving Average | 24.74 |
| Relative Strength Index (RSI) | 36.19 |
| Average Volume (20 Days) | 10,747,436 |
Short Selling Information
The latest short interest is 89,521, so 0.89% of the outstanding shares have been sold short.
| Short Interest | 89,521 |
| Short Previous Month | 194,483 |
| Short % of Shares Out | 0.89% |
| Short % of Float | 0.90% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, NewGenIvf Group had revenue of $4.73 million and earned $9.88 million in profits. Earnings per share was $3.04.
| Revenue | 4.73M |
| Gross Profit | 955,846 |
| Operating Income | -10.73M |
| Pretax Income | 9.73M |
| Net Income | 9.88M |
| EBITDA | -10.54M |
| EBIT | -10.73M |
| Earnings Per Share (EPS) | $3.04 |
Full Income StatementBalance Sheet
The company has $958,556 in cash and $4.87 million in debt, giving a net cash position of -$3.91 million or -$0.39 per share.
| Cash & Cash Equivalents | 958,556 |
| Total Debt | 4.87M |
| Net Cash | -3.91M |
| Net Cash Per Share | -$0.39 |
| Equity (Book Value) | 25.99M |
| Book Value Per Share | 110.50 |
| Working Capital | 5.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.93 million and capital expenditures -$135,025, giving a free cash flow of -$11.06 million.
| Operating Cash Flow | -10.93M |
| Capital Expenditures | -135,025 |
| Depreciation & Amortization | 188,109 |
| Net Borrowing | 6.19M |
| Free Cash Flow | -11.06M |
| FCF Per Share | -$1.10 |
Full Cash Flow StatementMargins
Gross margin is 20.22%, with operating and profit margins of -226.95% and 209.02%.
| Gross Margin | 20.22% |
| Operating Margin | -226.95% |
| Pretax Margin | 205.84% |
| Profit Margin | 209.02% |
| EBITDA Margin | -222.97% |
| EBIT Margin | -226.95% |
| FCF Margin | n/a |